KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Interest Coverage Ratio: 2010-2025

Historic Interest Coverage Ratio for Rigel Pharmaceuticals (RIGL) over the last 7 years, with Sep 2025 value amounting to 15.01.

  • Rigel Pharmaceuticals' Interest Coverage Ratio rose 119.91% to 15.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 15.70, marking a year-over-year increase of 1200.30%. This contributed to the annual value of 3.06 for FY2024, which is 202.47% up from last year.
  • Per Rigel Pharmaceuticals' latest filing, its Interest Coverage Ratio stood at 15.01 for Q3 2025, which was down 53.98% from 32.61 recorded in Q2 2025.
  • Rigel Pharmaceuticals' Interest Coverage Ratio's 5-year high stood at 86.09 during Q1 2021, with a 5-year trough of -22.79 in Q2 2022.
  • Its 3-year average for Interest Coverage Ratio is 4.69, with a median of 1.03 in 2023.
  • Per our database at Business Quant, Rigel Pharmaceuticals' Interest Coverage Ratio slumped by 207.17% in 2022 and then soared by 14,700.20% in 2025.
  • Over the past 5 years, Rigel Pharmaceuticals' Interest Coverage Ratio (Quarterly) stood at -16.49 in 2021, then spiked by 111.39% to 1.88 in 2022, then plummeted by 45.11% to 1.03 in 2023, then surged by 726.35% to 8.52 in 2024, then spiked by 119.91% to 15.01 in 2025.
  • Its last three reported values are 15.01 in Q3 2025, 32.61 for Q2 2025, and 6.89 during Q1 2025.